GuiWei C Achieved Counter-trend Growth with its Vitamin C Tablets

CSPC Innovation’s GuiWei C vitamin products have been considered by the industry as a way for Shijiazhuang Pharmaceutical Group to absorb the overcapacity of vitamin C production. However, in 2020, the main business income of CSPC Innovation’s health food products was RMB 496 million yuan (USD $76.23 million), with a year-on-year increase of 3.09%. In 2021, CSPC Innovation will continue to dig deeper into the vitamin C category, developing and launching VC granules for children and VC chewable tablets for pregnant and breastfeeding mothers. CSPC Innovation also actively promotes the health food research and development of vitamin B tablets, lutein blueberry eye care products, and coenzyme Q10 products. (Source: shuzhengkangxun)